Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: A randomized, double-blind, crossover study in healthy adult subjects
Authors:
- Catherine DattoCDCatherine Datto
- Lovisa BerggrenLBLovisa Berggren
- Jitendra B. PatelJPJitendra B. Patel
- Hans ErikssonHEHans Eriksson
- 1 March 2009
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 31 (3) , 492-502
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Efficacy of Quetiapine Monotherapy for the Treatment of Depressive Episodes in Bipolar I DisorderThe Journal of Clinical Psychiatry, 2008
- Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophreniaInternational Clinical Psychopharmacology, 2008
- Switching from other antipsychotics to once-daily extended release quetiapine fumarate in patients with schizophreniaCurrent Medical Research and Opinion, 2008
- Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Acute SchizophreniaThe Journal of Clinical Psychiatry, 2007
- Disability and its treatment in bipolar disorder patientsBipolar Disorders, 2007
- Efficacy of Quetiapine Monotherapy in Bipolar I and II DepressionJournal of Clinical Psychopharmacology, 2006
- Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007Bipolar Disorders, 2006
- Treatment adherence with antipsychotic medications in bipolar disorderBipolar Disorders, 2006
- A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II DepressionAmerican Journal of Psychiatry, 2005
- The use of analogue scales in rating subjective feelingsPsychology and Psychotherapy: Theory, Research and Practice, 1974